Position in IDXX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$465,372
-$220,133 QoQ
Shares Held
884
-27.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#791
of 1,286 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $18,008,712 across 10 Diagnostics & Research names. IDXX ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
33,838 | $5,877,998 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
8,954 | $4,489,176 | |
| 3 | DHR |
Danaher Corp /De/
|
11,204 | $2,134,137 | |
| 4 | ILMN |
Illumina, Inc.
|
8,265 | $1,453,233 | |
| 5 | DGX |
Quest Diagnostics Inc
|
6,013 | $1,274,454 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
4,662 | $900,790 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
1,118 | $592,081 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
This page
|
884 | $465,372 |
All Filings in IDXX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $465,372 | 884 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $685,505 | 1,220 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $706,296 | 1,044 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $718,750 | 1,125 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $404,936 | 755 | Shares | Sole | 2025-08-04 | |
| 2021-06-30 | $1,894 | 3 | Shares | Sole | 2021-07-28 | |
| No filing history on record for this holder in this stock. | ||||||